1. Home
  2. BIO vs MTZ Comparison

BIO vs MTZ Comparison

Compare BIO & MTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • MTZ
  • Stock Information
  • Founded
  • BIO 1952
  • MTZ 1929
  • Country
  • BIO United States
  • MTZ United States
  • Employees
  • BIO N/A
  • MTZ N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • MTZ Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • BIO Industrials
  • MTZ Industrials
  • Exchange
  • BIO Nasdaq
  • MTZ Nasdaq
  • Market Cap
  • BIO 9.1B
  • MTZ 10.8B
  • IPO Year
  • BIO N/A
  • MTZ N/A
  • Fundamental
  • Price
  • BIO $342.01
  • MTZ $150.57
  • Analyst Decision
  • BIO Strong Buy
  • MTZ Strong Buy
  • Analyst Count
  • BIO 4
  • MTZ 15
  • Target Price
  • BIO $414.00
  • MTZ $152.73
  • AVG Volume (30 Days)
  • BIO 158.1K
  • MTZ 816.8K
  • Earning Date
  • BIO 02-13-2025
  • MTZ 02-27-2025
  • Dividend Yield
  • BIO N/A
  • MTZ N/A
  • EPS Growth
  • BIO N/A
  • MTZ N/A
  • EPS
  • BIO N/A
  • MTZ 1.13
  • Revenue
  • BIO $2,580,209,000.00
  • MTZ $12,180,445,000.00
  • Revenue This Year
  • BIO N/A
  • MTZ $2.91
  • Revenue Next Year
  • BIO $2.92
  • MTZ $8.82
  • P/E Ratio
  • BIO N/A
  • MTZ $133.60
  • Revenue Growth
  • BIO N/A
  • MTZ 3.89
  • 52 Week Low
  • BIO $262.12
  • MTZ $60.96
  • 52 Week High
  • BIO $387.99
  • MTZ $152.84
  • Technical
  • Relative Strength Index (RSI)
  • BIO 53.78
  • MTZ 65.66
  • Support Level
  • BIO $335.42
  • MTZ $132.18
  • Resistance Level
  • BIO $351.96
  • MTZ $150.55
  • Average True Range (ATR)
  • BIO 9.09
  • MTZ 4.49
  • MACD
  • BIO 2.06
  • MTZ 0.99
  • Stochastic Oscillator
  • BIO 59.23
  • MTZ 89.01

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About MTZ MasTec Inc.

MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. The company's primary activities include the engineering, building, installation, maintenance, and upgrade of communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five reportable segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.

Share on Social Networks: